Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.

MLA

Jafri, S. M., et al. “Hemodynamic Effects of a New Type III Phosphodiesterase Inhibitor (CI-914) for Congestive Heart Failure.” The American Journal of Cardiology, vol. 57, no. 4, Feb. 1986, pp. 254–59. EBSCOhost, https://doi.org/10.1016/0002-9149(86)90901-x.

APA

Jafri, S. M., Burlew, B. S., Goldberg, A. D., Rogers, A., & Goldstein, S. (1986). Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure. The American Journal of Cardiology, 57(4), 254–259. https://doi.org/10.1016/0002-9149(86)90901-x

Chicago

Jafri, S M, B S Burlew, A D Goldberg, A Rogers, and S Goldstein. 1986. “Hemodynamic Effects of a New Type III Phosphodiesterase Inhibitor (CI-914) for Congestive Heart Failure.” The American Journal of Cardiology 57 (4): 254–59. doi:10.1016/0002-9149(86)90901-x.